据印度代购了解，虽然多吉美主要是用于治疗肝癌晚期的患者，但是部分服用易瑞沙的患者出现耐药后尝试使用多吉美，发现很有效果。

According to Daigou India, although dogemet is mainly used for the treatment of patients with advanced liver cancer, some patients taking Iressa tried to use dogemet after developing drug resistance, and found it was very effective.

据印度代购了解，关于使用多吉美抗易瑞沙耐药的方法：一天一次，一次一粒，早晨服用后，肺癌病人易瑞沙耐药后的病情减轻疗效不错，但随后的副作用也体现出来，副作用开始时是手足综合症，后期接着就是口腔粘膜红肿、腹痛、腹泻等，其中关节疼，身上起红斑比较常见，在这之后的两三个月发现病情有所进展，就又加了用量，改为一天两次一次一粒，病情不在有进展，得到有效的控制!

据印度代购了解，这种方法对于广大肺癌易瑞沙耐药的患者来说是个好事儿，可以延长使用时间。

According to Daigou India, this method is a good thing for the majority of patients with lung cancer resistant to iressa, which can prolong the use time.